Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20125696 | 0.84 | EPHX1 (0.37) | TSHRSMN1; SMN2 | |
| SCHEMBL5137869 | 0.83 | CYP3A4 (0.32) | TSHRSMN1; SMN2 | |
| SCHEMBL12851469 | 0.83 | CYP3A4 (0.32) | TSHRSMN1; SMN2 | |
| SCHEMBL17449732 | 0.83 | CYP3A4 (0.32) | TSHRSMN1; SMN2 | |
| SCHEMBL8024973 | 0.80 | — | — | |
| SCHEMBL20125698 | 0.74 | CYP3A4 (0.31) | TSHRSMN1; SMN2 | |
| SCHEMBL20648570 | 0.74 | TSHR (0.32) | TSHR | |
| SCHEMBL12773076 | 0.72 | — | — | |
| SCHEMBL10331496 | 0.71 | TRPA1 (0.50) | SMN1; SMN2 | |
| SCHEMBL24295875 | 0.71 | NOS2 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |